Excigen Inc.
This article was originally published in Start Up
Executive Summary
Excigen aims to develop a new a new line of defense against cardiac arrhythmias--one based on gene therapy--that avoids the pitfalls of current treatments. In particular, the company is working on a gene therapy for AF and a genetically engineered biological pacemaker